The approval was supported by a systematic review of published literature that included 46 patients with FOLR1-CFTD treated with leucovorin through various administration routes. The Food and Drug ...
The FDA’s actions have been unusual from the start of this leucovorin saga. The decades-old drug is often used to help cancer patients fight side effects of chemotherapy and other treatments that ...
A medication used primarily to help relieve the side effects of chemotherapy has been given the green light to be used as a treatment for a rare neurological disorder. However, the FDA announcement ...
The US Food and Drug Administration (FDA) has granted its approval for the expanded use of GSK’s Wellcovorin (leucovorin calcium) tablets to treat cerebral folate deficiency (CFD) in patients with a ...
Corrections and clarifications: Due to an editing error, a previous version of this story mischaracterized the scope of the new FDA approval for leucovorin. In a White House briefing on Sept. 22, ...
US regulators have withdrawn their approval of a GSK Plc drug that the Trump administration had promoted as a treatment for autism, adding another twist to the unusual story of a decades-old drug.
At a press conference in late 2025, federal officials made some big claims about leucovorin, a prescription drug usually reserved for people on cancer chemotherapy. "We're going to change the label to ...
ATLANTA — The prescription drug leucovorin is getting a label update, but it's not what the Food and Drug Administration suggested during a White House briefing in September, when officials touted the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results